Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For April 26 (XOM, EA, PATK, REGN, AET, UPS, TWC, CELG, FURX)

RELATED NEWS
Trade XOM now with 

Gainers:

Electronic Arts Inc. (EA: Quote) is rising 8 percent to $16.19 based on a report that Japan's Nexon is reportedly planning to make an offer for the company.

Patrick Industries, Inc. (PATK: Quote) is gaining 17 percent to $10.50. The company swung to a profit in its first quarter. Net sales rose 47.8 percent.

Regeneron Pharmaceuticals, Inc. (REGN: Quote) is up 12 percent to $142.36. The company reported a profit in its first quarter, versus a loss in the last year quarter. Revenues jumped from the year-ago quarter and were above consensus.

Decliners:

Aetna Inc. (AET: Quote) is down 9 percent to $44.90 as the company's first quarter profit declined from the year-ago quarter and were below Wall Street view. The company reaffirmed its full-year 2012 operating earnings per share guidance, which is below analysts' estimate.

Exxon Mobil Corp. (XOM: Quote) is falling over 1 percent to $85.80. The company's first quarter profit declined from the previous year period and was below the consensus estimate.

United Parcel Service, Inc. (UPS: Quote) is falling more than 3 percent to $77.19. The company's first quarter improved jumped from the year-ago quarter, but was below Wall Street view. Revenues rose 4.4 percent, but fell short of the consensus estimate. In addition, the company said it remains confident in its 2012 earnings per share guidance.

Time Warner Cable Inc. (TWC: Quote) is falling 1 percent to $81.00. The company's first quarter profit increased from the previous year. Total revenues improved 6.4 percent and were in-line with analysts' view.

Celgene Corp. (CELG: Quote) is falling 3 percent to $75.39 as the company's first quarter non-GAAP earnings per share and revenue were below consensus.

Furiex Pharmaceuticals Inc. (FURX) is plunging 27 percent to $14.22 based on the news that its partner Takeda has received a Complete Response Letter from the FDA regarding NDAs for Alogliptin and the fixed-dose combination therapy Alogliptin and pioglitazone.

Register
To receive FREE breaking news email alerts for Exxon Mobil Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.